Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.4    
    

Milloni Notary's Offices

Via XXV Aprile No. 13 Arezzo

Telephone: 23393123394—Fax 353885  

	Index No. 86821	 	Collection No. 21263

CONTRACT
FOR CURRENT ACCOUNT CREDIT WITH MORTGAGE

LIEN PURSUANT TO ARTICLE 38 AND SUBSEQUENT ARTICLES OF

LEGISLATIVE DECREE No. 385/1993 

REPUBLIC OF ITALY

July 10,
2003 

(7/10/2003)

        In
Arezzo, at Via Guido Monaco at the Bank's premises. 

        Before
me, Dr. Fabio Milloni, Notary in Arezzo, member of the Arezzo District Board of Notaries, without the presence of witnesses by express and mutual waiver granted, with my
consent, by the parties present 

APPEARED THE FOLLOWING  

        (A)  for
"Unicredit Banca d'Impresa S.p.A." member of the Bank Registry—code ABI 03226.8 and belonging to the Unicredit Italian Banking Group—member
of the Banking Group Registry, code 3135.1—with legal and general headquarters in Verona, Via Giuseppe Garibaldi No. 1, with capital stock of EUR 3,671,300,000.00 fully paid,
membership in the Verona Company Registry, Tax code and VAT No. 03656170960, member of the Interbank Fund for the protection of deposits, (hereinafter referred to as the "Bank"). MARIO BRIZZI,
born in Arezzo on February 21, 1953; UMBERTO VALIANI, born in Florence on October 2, 1949, domiciled, for the purposes of their position, at the Arezzo Branch which represents the Bank
pursuant to the power of attorney issued by the Chairman of the Board of Directors on January 2, 2003, document drawn by the Notary Cicogna (Index No. 87071) filed in Verona on January
07, 2003 under No. 37, attached under letter "A" to my previous deed dated July 4, 2003 (Catalog No. 86740), the associated formalities being underway. 

        (B)  as
representatives of MAGNETEK SPA (the "Company") with headquarters in Terranuova Bracciolini (Arezzo), Via San Giorgio No. 642, with capital stock of EUR
22,000,000.00, member of the Verona Company Registry under No. 9683 on March 10, 1992, tax code 09286180154: 

        ANTONIO
CANOVA, born in Viareggio (Lucca) on May 21, 1942, serving as Vice Chairman of the Board of Directors; 

        ALBERTO
CORDINI, born in Milan on December 14, 1950, serving as a member of the Board of Directors; 

both
domiciled for the purposes of their position at the headquarters of the aforementioned company, duly authorized to enter into this agreement pursuant to a resolution of the Board of Directors
dated June 9, 2003, seen by me, as Notary. 

        These
gentlemen, whose personal identity and position I, the Notary, am certain of, having waived the presence of witnesses, by agreement among themselves and myself. 

DO HEREBY ENTER INTO THE FOLLOWING AGREEMENT  

Article 1—Purpose of funding and amount  

        Pursuant to Article 38 ff. of Legislative Decree No. 385/1993 (hereinafter "T.U.B." [Unified Banking Regulations]), the Bank
grants "MAGNETEK S.P.A." (hereinafter the "Company"), which accepts, financing in the form of a loan on a current account backed by a mortgage lien for a total of EUR 7,000,000.00 (seven million point
zero) for investments without specific purpose as per the associated documentation. 

        For
this purpose a current account is being opened in the Company's name, intended solely for the use and the repayment of the loan. The Company may operate on this account only through
bank withdrawals and deposits, debit/credit transactions, to be transferred to and from the current account held by said Company at the Bank. Operations through bank checks are excluded. 

        Opening
this line of credit shall be accepted under all the conditions provided for in this Contract. 

Article 2—Conditions for Financing  

        The Company may use the credit line provided it has properly fulfilled all obligations and conditions provided for in this document and has presented the Bank
with the following documents: 

        (a)   a
notarized declaration showing the completed registration and the relevant data of the mortgage associated with this Contract, attesting that at the time of said filing
the real estate offered as security
was fully owned by the mortgagee and that on said real estate there were no liens, registrations, prejudicial formalities other than those indicated in Art. 8 below; 

        (b)   two
certified copies of this Contract as well as a duplicate of the mortgage registration note; 

        (c)   a
statement from an expert attesting that the mortgaged property complies with regulations; 

        (d)   the
insurance policy pursuant to Art. 13 below; 

        (e)   a
certificate stating that no bankruptcy proceedings exist against the Company, updated recently, that being within ten days following the mortgage registration; 

        (f)    the
complete documentation of the investment program as mentioned in Art. 1 of this Contract. 

        Failure
to submit these documents within the deadline of one month on the part of the Company will attest to said Company's renunciation of the financing granted, whereby the Bank may
deem itself free from any commitment undertaken with this Contract, once said deadline is past. 

        Expenses
and charges incurred in any manner by the Bank charged to the Company, which will provide to pay them within 15 (fifteen) days from the request.
[sic] 

Article 3—Repayment Terms and Procedures  

        The term of the credit in the current account will last until September 30, 2013. 

        The
amount will be gradually and automatically decreased without need for written communication by the Bank, according to the schedule agreed on by the parties, signed by the parties and
by me as Notary, and which is attached to this Contract under letter "A," to become an integral and essential part thereof. 

        The
Company commits, under penalty of rescission of the loan, to make the payments to the current account needed to service the debt within the limits set in said schedule, including the
interest which will accrue, and this without express request by the Bank. 

        Within
the limits of the credit line, the use of the amounts made available by the Bank may take place in one or more times. 

Article 4—Interest  

        Quarterly variable rate interest will accrue in favor of the Bank on the amounts owed by the Company, within the limits set in the attached repayment schedule,
with a nominal yearly rate equal to the price in force for a three-month Euribor multiplied by the coefficient 365/360, rounded upwards to the next 0.05% (zero point zero five percent), the value date
to run for each calendar quarter, and adjustable every three months commencing from October 1, 2003, increased by 1.50 (one point fifty) percentage points per year. 

        In
the event that use of the credit line is allowed earlier than the effective date for the repayment schedule, and in any case up to September 30, 2003, the Company must pay
interest for that period of 3.70% (three point seventy percent) nominal per year (corresponding to an effective yearly rate of 3.75% (three point seventy-five percent). This corresponds to
the current rate for a three-month Euribor multiplied by the coefficient 365/360, rounded upwards to the next 0.05% (zero point zero five percent), as of the value date of this Contract, increased by
1.50 (one point fifty) percentage points per year. 

        Interest
calculated as above will, in any case, be debited to the current account at the end of each calendar quarter. The balance resulting from the periodic quarterly closing will
produce interest at the rate calculated above and will be compounded quarterly. 

        On
the amounts owed by the Company, in excess of the limits set in the attached repayment schedule, interest shall accrue to the bank at the maximum debit rate for uses over the amount
of the credit line, currently equal to 13.25% (thirteen point twenty-five) nominal yearly, (13.92% (thirteen point ninety-two percent) effective per year), with the same
periodicity indicated above, as set out in the "analytical information sheet" regarding transfer accounts in force at that time and available at the Bank's offices which are open to the public in
compliance with the legal provisions on transparency of the contractual conditions applied. 

        In
the absence of a Euribor approximation by the EURIBOR PANEL STEERING COMMITTEE, the Euro Libor on the London market shall be used. 

        For
all which is not expressly regulated by this Contract, the "General Rules which regulate transfer accounts and associated services" which the Company holding the current account
declares to know well and to accept, will apply, to the extent they are compatible. 

Article 5—Late Payment  

        In the event of expiration of the time limit and of rescission of the contract, interest charged for late payment on the amounts owed by the company for any
reason and arising from the financing will rightfully accrue in favor of the Bank from the date they occur at the contractual rate currently in force, increased by 2 (two) points per year. 

        Said
interest will not be compounded. 

Article 6—Commissions And Expenses  

        Pursuant to and by the effect of Title VI, chapter I of the T.U.B, following commissions and expenses will apply to the financing: 

        (a)   Service
commission of EUR 3,000.00 (three thousand point zero). 

        Moreover,
the expenses connected with this Contract, including those associated with the issuance of certified copies, as well as those associated with the inspection and mortgage
registration formalities shall be borne by the Company. 

        The
Bank reserves the right to modify the financial terms set out under letter (a), complying, with the provisions set out in Articles 118 and 161, second paragraph of the T.U.B. and
related implementation instructions, in the event of changes unfavorable to the Company,. The Mortgagee approves
specifically—pursuant to Art. 117, fifth paragraph of the T.U.B.—said right of the Bank. 

        Any
expenses arising from the financing during the entire term of same will be charged to the Company to the extent provided in the specific "analytical information sheet" in force at
that time, and available at the Bank's offices which are open to the public in compliance with the legal provisions on transparency of the contractual conditions applied. 

        For
the expenses and notary fees, Art. 39 seventh paragraph of the TUB shall apply. 

Article 7—Domicile  

        For all legal purposes, and also for the purpose of the mortgage registration, the Bank's elective domicile is at the Arezzo Branch. 

        The
Bank may be served any document, including executive ones, at the Company's address in Terranuova Bracciolini, Via San Giorgio 642 or, if not reachable there, at the Terranuova
Bracciolini municipal building; or at the elective or actual domicile of the Company. 

Article 8—Mortgage  

        As a security for the timely repayment of the credit, pursuant to the attached repayment schedule, also in the event of extending the deadline, as well as the
exact fulfillment of all the obligations deriving from this Contract, pursuant to Articles 38, 39, 40 and 41 of the T.U.B., the Company allows the Bank to file a 

MORTGAGE  

on
the building and accessions, improvements and relating appurtenances, as per the following description: 

        Area
with the buildings on it, located in the municipality of Terranuova Bracciolini, Via San Giorgio 642 and precisely: 

	•
	MAIN
PLANT: a rectangular manufacturing building, where the various production departments are located, the testing and trial offices, storage areas, locker rooms and
restrooms, technical and technological centers, the Enel electrical closet; the building is laid out in full on a single floor at ground level and it has a small basement.

	•
	ACCESSORY
BUILDING: a manufacturing building on two floors: on the ground floor there is a machine shop, a storage area, a thermal plant; the first floor holds the company
cafeteria.—GUARDHOUSE; this is the watchman's post and telephone central, located at the plant entrance.—ACCESSORIES: bicycle canopy, water storage and fire fighting center;
storage rooms for garbage, flammable and harmful materials. 

        The
above is identified at the N.C.E.U. (Nuovo Catasto Edilizio Urbano/New Urban Building Tax Inventory) of the Municipality of Terranuova Bracciolini, on page 47, part 19,
subsection 3, Category D/7, with real estate income of EUR 114,302.24; part 25, of 4,549 square meters; part 321, of 1,737 square meters; part 444 of 40 square meters;
part 445, of 699 square meters; part 446, of 38 square meters; part 447, of 11 square meters and at the N.C.T. of the Municipality of Terranuova Bracciolini, on page 47, the
following parts: part 7, Class 2, of 1 (one) hectare, areas 93 (ninety-three), 30 (thirty) centares, with landlord income of EUR 160.73 and withholding tax of EUR 59.90; part 222,
Class 2, of hectares 0, (zero) areas 69 (sixty-nine), 8 (eight) centares with landlord income of EUR 57.08 and withholding tax of EUR 21.42. 

        Borders:
Public Street, Residual property, again Public Street, unless there are others. 

        This
mortgage is granted for the total amount of EUR 14,000,000.00 (fourteen million point zero), which is presumed to include: 

EUR
7,000,000.00 (seven million point zero) for financed capital; 

interest,
including late interest, in the adjustable measure provided by Articles 3 and 4 of this Contract; 

expenses,
including legal ones, (including those as per the first paragraph of Art. 2855 of the Italian Civil Code), insurance premiums, taxes, duties and any other amount which may represent a credit
to the Bank arising from this Contract or from law, also for cases of rescission or expiration of time limit. 

        Pursuant
to Art. 39, third paragraph of the T.U.B., the Bank's credit is guaranteed by the registered mortgage up to the entire amount actually owed, by effect of the index clauses
outlined in Articles 4 and 5 of this Contract. 

        The
mortgagee agrees that on anyone's request this mortgage may be registered with the appropriate office for land registry service, with indemnification of same from any responsibility
in the matter. 

        The
mortgagee declares, assuming all resulting responsibility, that it holds full and exclusive ownership of the real estate, which is not subject to any registration or lien, nor to any
prior note, or hidden easements or any other encumbrance or charges, including those for taxes or town planning schemes which may prejudice or diminish the mortgage lien granted against the credit
with the exception of: 

	•
	mortgage
registered in favor of the CASSA DI RISPARMIO DI FIRENZE S.P.A. and of the ISTITUTO MOBILIARE ITALIANO S.P.A., created on June 10, 1995 under procedure
No. 1,159, for a total of LIT 11,000,000,000 (eleven billion), balance of LIT 6,000,000,000 (six billion) and with a term of 7 (seven) years;

	•
	mortgage
registered in favor of MEDIOCREDITO TOSCANO S.P.A., created on March 7, 1997 under procedure No. 451 for a total of LIT 10,000,000,000 (ten billion)
balance of LIT 5,000,000,000 (five billion) and with a term of 4 (four) years. 

Article 9—Truthfulness and authenticity of the declarations  

        The Company confirms the truthfulness and authenticity of the communications made and the documentation submitted to the Bank and it affirms that its economic,
financial and equity position have not undergone any negative changes subsequent to the submission of the application for financing. 

Article 10—Modifications to the Repayment Schedule  

        The Bank, at its own sole discretion, may agree to modify the repayment schedule. 

Article 11—Joint and Several Obligations  

        All obligations deriving from the contract are assumed by the Company also on behalf of its own successors or assignees with the bonds of joint and several
liability. 

Article 12—Allocation of Payment  

        The Bank may allocate any amount paid by the Company or on the latter's behalf, according to the following priorities; first, to the payment of expenses of any
kind, including legal ones, repeatable or not, as well as to any reimbursement of insurance premiums and of anything else which may have been paid by the Bank on behalf of the Company, next, for the
settlement of any interest charged for late payment and of arrears, and finally to the payment of the corresponding interest and principal, and this unless it deems to adopt a different order of
allocation. 

Article 13—Payments made by Third Parties  

        The Bank will have the right to refuse payments made by third parties on their own initiative. 

Article 14—Orders given after the deadline or the rescission of the contract  

        Any orders given by the Company, which the Bank deems to have been implemented after the deadline or after the rescission of the contract, do not imply the
reinstatement of the line of credit, not even for the amount of the order. Any overdrafts, allowed beyond the limit of the loan, do not imply the increase of the limit. 

Article 15—Inspection of the mortgaged property and decrease of securities  

        The Bank may at any time have the mortgaged properties inspected by a trusted individual for whom the Company, the third party mortgagee and their successors or
assignees for any reason must, if requested to do so, prepare the necessary means to fulfill his/her task. 

        In
the event that, for any reason, none excluded or excepted, a decrease in value of the mortgaged property were to take place, such as to diminish, in the Bank's sole opinion, the
margin of security ascertained in the loan granting process, the Bank will have the right to request, depending on the case, an appropriate mortgage supplement, another suitable security, the partial
return of the loan or the rescission of the contract. 

Article 16—Obligations  

        The Company is obligated to: 

        (a)   pay
in a timely manner, supplying proof at the Bank's request: 

any
tax, duty, rates, contributions and encumbrance on the mortgaged properties, as well as the premiums associated with the insurance policies; to pay the Bank, at the time of entering into the
contract, the substitute tax pursuant to Presidential Decree No. 601 of September 29, 1973 and its subsequent modifications and additions and to repay, in any event, the Bank for any
taxes, duties and expenses of any kind incurred or paid on their behalf, including the amount which the Bank itself may have had to pay or will have to pay for counsel and assistance, both judicial
and extra judicial provided to it, without prejudice, naturally, to all the securities acquired against this Contract; 

        (b)   maintain
the assets given as security in excellent condition with good and reasonable care, and to perform, therefore, any repairs and any work needed for their
preservation and not modify their features unless with the Bank's prior authorization; 

        (c)   refrain
from doing, nor tolerate others doing, anything which may impair the substance of the security and, in particular, not to mortgage and not to change the
disposition and the substance of the assets (for instance, in the case of the mortgaged properties, by demolishing them even only in part, even if for the purpose of improvements or rebuilding)
without prior written authorization by the Bank; 

        (d)   refrain
from altering the legal condition of the properties; 

        (e)   give
the Bank, without delay, notice of any intrusion and challenge by a third party to the ownership rights on the mortgaged property, and changes which, for any cause,
even not attributed to themselves, were to take place in the real property, including condemnation by the right of eminent domain, as well as any event which may negatively modify the substance and
the value of the security given; 

        (f)    leave
the mortgaged property, or any part thereof, vacant and free of persons and personal property in the event that the Bank, or anyone acting in the Bank's behalf,
were to take possession of the real property; 

        (g)   notify
the Bank in advance of any changes to the legal or corporate structure (i.e., legal format and share capital, changes to the Board of Directors or board of
Auditors or the shareholders, as well as mergers, also through acquisitions, splits, divestitures, transfers) or changes in the administrative, capital or financial structure (i.e., bond issue), as
well as the financial and technical situation as results from the data, elements and documents supplied at the time of the loan application, as well as facts which may in any way modify the Company's
current structure and organization; 

        (h)   inform
the Bank in advance of the intention to request medium/long term loans from other lending institutions or private individuals; 

        (i)    be
available for the completion of any formalities and be present at any time for the drawing up of any document requested by the Bank, also for the ascertainment,
better identification or investigation of the assets delivered as security, either as confirmation of the real guarantees agreed upon, or to correct errors or omissions; the authorization of the
consequent notes, transcriptions, insertions: 

        (l)    allow
any type of technical-administrative investigation or inspection and to supply all documents (balance sheets, minutes of meetings, etc.) including those for the
implementation of the program financed, and the information which was to be requested by the Bank; 

        (m)  give
additional security pursuant as regards Art. 15 above within thirty days from the request; 

Article 17—Insurance  

        The Company commits to insure the real property, included in the mortgage security and the furnishings, even if owned by a third party, subject to special
easement, against damage from fire, gas explosions, lightening strikes, explosions and other risks indicated by the Bank, for the entire term of the loan and in any event, until any reason of credit
by the bank has been satisfied. The insurance will be obtained from an Insurance company approved by the Bank and for a value deemed adequate by the same. The policies, which must show the necessary
data for the exact identification of the assets, must contain a lien in favor of the Bank and remain deposited with the bank. 

        The
Company also commits, to pay the insurance premiums fifteen days before the due date and to furnish proof of the payment; in case of a failure to do so, the Bank is authorized to see
directly to the right of reimbursement from the Company for the principal, interests and expenses. 

        It
is also the Bank's right to stipulate the insurance in its own name with a company of its choice and charge the Company during the validity period of the loan, if, deeming that it was
not sufficiently covered by the insurance company, or that it had requested the Company to replace the insurance company, and the latter had not complied with the request. 

        In
the case of damage, the Company and any other grantor of real guarantee must, on penalty of rescission of the contract, inform the Bank within three days. The Bank will have the right
to intervene, at the Company's expense, in the damage ascertainment activities or to promote them if it deems it to be to its advantage. 

        The
amount due by the insurance company as loss or deterioration indemnities must be paid to the Bank for the total or partial satisfaction of the debt, according to the Bank's
unquestionable opinion. 

Art. 18—Rescission and expiration of time limit  

        The Bank will have the right to declare the expiration of the time limit in the event of the occurrence of the hypotheses set out in Art. 1456 of the Italian
Civil Code in the event that: 

        (a)   the
Company should allocate, even only in part, the loan for purposes other than those for which it was granted; 

        (b)   the
Company and its successors or assignees do not arrange for the repayment of the loan according to the specific repayment schedule provided, or if they do not repay
what was due to the Bank for any reason whatsoever associated to the loan (i.e., principal, interest, commissions, expenses, including legal ones, taxes, duties, etc.); 

        (c)   the
occurrence of late payment pursuant to Art. 40, second paragraph of the Legislative Decree No. 385/1993; 

        (d)   the
documentation requested in Art. 2 of the contract is not produced; 

        (e)   the
contract of insurance for damages to the assets given as security were to be rescinded in any way, and it were not possible, for any reason whatsoever, to enter into
another with a company approved by the Bank; 

        (f)    the
occurrence mentioned in the second to last paragraph of Art. 17 above were to take place; 

        (g)   the
Company and any mortgagee had received advance rent installments for the mortgaged property not reported to the Bank before entering into the contract; 

        (h)   the
Company and any mortgagee failed to disclose debts for duties, fees, services of any kind and taxes with precedence on the Bank's credit, or the existence of rights
of common or other liens or charges which would diminish the security; 

        (i)    execution
proceedings or preventive remedies were filed against the Company and the mortgagee, or if it were to become in any way insolvent or, for any reason or event
(i.e., protest, filing of concurrence proceedings, any changes in the legal-corporate structure—for instance, legal format and share capital, changes in the Board of Directors or the board
of Auditors or in the shareholders, as well as mergers, also through acquisitions, splits, divestitures, administrative or capital transfers or changes in the administrative or financial structure
etc.) in the Bank's sole opinion, there should be a danger of prejudice of any kind towards the credit or the guarantees; 

        (j)    it
is found that the positions, the data and the accounts presented or declared by the Company to the Bank both during the period of the granting of the loan or
subsequently do not correspond to the truth; 

        (k)   the
recovery of the amounts paid on behalf of the Company are for any reason hindered by provisions of law; 

        (l)    facts
emerge or defects are discovered in the documents that if known or checked earlier, would have been stopped, such as, in the Bank's sole opinion, the granting of
the loan, or if it were to be found, in any way, that the position, the data and the accounts presented or declared by the Company to the Bank both during the period of the granting of the loan or
subsequently do not correspond to the truth; 

        (m)  the
occurrence mentioned in the second to last paragraph of Art. 2 were to take place; 

        (n)   the
Company does not satisfy even one of the obligations set out in Art. 16 above; 

        (o)   the
balance sheet data does not comply with the following parameters: 

	•
	EBITDA/sales
revenue: no lower than 10% (ten percent);

	•
	net
financial debt/shareholders' equity not to exceed 35% (thirty-five percent). 

        In
these cases the Bank will have the right to demand the immediate repayment of all its credit, and to do so without the need for any prior formality in the manner and the procedure it
will deem most opportune. In any event, all the guarantees contractually constituted as well as those subsequently acquired will remain in place. 

Art. 19—Non-involvement in relations between the Company and third parties  

        The bank, with the exception of an explicit declaration to the contrary, must always consider itself not involved in the relations between the Company and third
parties, so that the latter may never raise any claims or demands against the Bank. 

Art. 20—Court having jurisdiction  

        For any dispute arising from the financing, the Court to have jurisdiction for proceedings filed by the Company and by the Guarantors is solely that of the Bank's
legal headquarters, that is, Verona. The bank, instead, has the right to act against the Company and the Guarantors at its own unquestionable choice, even in any of the Courts provided by law, as well
as in the Court of the district where the Bank's Branch is located and where the loan relationship was instituted. 

        This
document and the associated formalities are subject to the treatment provided for in Art. 15 ff. of the Presidential Decree No. 601 of September 29, 1973 (exemption
from recording tax, stamp tax, mortgage tax and cadastral tax and from taxes on government concessions, instead of which the Bank will pay a substitute tax on the aggregate amount of the loans granted
in each fiscal year). 

        In
addition to the amount of the substitute tax paid to the Bank, to the extent applicable at the time the contract was entered into, the party commits to pay the Bank any increase of
the tax which the Bank would have had to pay relative to this document through subsequent provisions of the law, 

        The
parties declare that they are already acquainted with the attachments herein and therefore they dispense me, the Notary, from reading the same. Upon request I, the Notary, received
this document and read it to the parties, who approve it and execute it together with me, the Notary. 

        This
takes, up to this point, twenty-three pages of six sheets written in part by mechanical means by a person I trust and in part by hand, by me as Notary. 

signed:
Brizzi Mario 

signed:
Valiani Umberto 

signed:
Canova Antonio 

signed:
Cardini Alberto 

signed:
Fabio Milloni Notary. 

FOLDER
NO. 2163 AREZZO 07/10/2003 

 
 

FUNDING AMORTIZATION SCHEDULE
  MORTGAGE BACKED LINE OF CREDIT    

Aggregate
No. 00                            AREZZO 

[illegible]
07/10/2003                        Original
Principal                        7,000,000.00 

	Due date
 
	 	Residual before
	 	Principal Shares
	 	Interest shares
	 	Other items
	 	Net installment
	 	Currency
	 	Period Rate

	12/31/2003	 	7,000,000.00	 	145,415.94	 	64,750.00	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	3/31/2004	 	6,854,584.06	 	146,761,03	 	63,404.90	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	6/30/2004	 	6,707,823.05	 	148,118.57	 	63,047.36	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	9/30/2004	 	6,559,704.46	 	149,488.67	 	60,677.27	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	12/31/2004	 	6,410,215.79	 	150,071.44	 	59,291.50	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	3/31/2005	 	6,259,344.35	 	152,267.00	 	57,893.94	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	6/30/2005	 	6,107,077.35	 	153,675.47	 	56,490.47	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	9/30/2005	 	5,953,401.03	 	155,096.97	 	55,068.97	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	12/31/2005	 	5,798,304.91	 	156,531.62	 	53,634.32	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	3/31/2006	 	5,641,773.29	 	157,979.53	 	52,106.40	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	6/30/2006	 	5,403,793.76	 	159,440.04	 	50,725.09	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	9/30/2006	 	5,324,352.02	 	160,915.67	 	49,250.26	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	12/31/2006	 	5,163,437.25	 	162,404.14	 	47,761.79	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	3/31/2007	 	5,001,033.11	 	163,906.38	 	46,259.56	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	6/30/2007	 	4,037,126.13	 	165,422.51	 	44,713.42	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	9/30/2007	 	4,671,704.22	 	166,952.67	 	43,213.26	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	12/31/2007	 	4,504,751.55	 	168,496.98	 	41,660.95	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	3/31/2008	 	4,336,254.57	 	170,055.58	 	40,110.35	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	6/30/2008	 	[illegible] 198.99	 	171,628.60	 	38,537.34	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	9/30/2008	 	[illegible]	 	173,216.16	 	36,949.78	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	12/31/2008	 	[illegible]28	 	174,618.41	 	35,547.53	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	3/31/2009	 	3,646,535.82	 	176,435.48	 	33,730.46	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	

[illegible] calculated on the basis of the last value assumed by the variable rate are indicative.	
 	

EUR	
 	

 
	

[illegible]	
 	

EUR	
 	

 
	

[notary stamp]	
 	

[signature]	
 	

[signature]	
 	
MORTGAGE AMORTIZATION SCHEDULE Form XA003c Version 01
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

	6/30/2009	 	3,470,100.34	 	178,067.51	 	32,098.43	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	9/30/2009	 	3,292,032.83	 	179,714.63	 	30,451.30	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	12/31/2009	 	3,112,318.20	 	181,376.94	 	28,788.91	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	3/31/2010	 	2,930,941.21	 	183,054.73	 	27,111.21	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	6/30/2010	 	2,747,806.40	 	184,747.99	 	25,417.55	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	9/30/2010	 	2,563,130.49	 	186,156.91	 	23,709.03	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	12/31/2010	 	2,376,681.58	 	188,101.63	 	21,904.30	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	3/31/2011	 	2,108,499.95	 	189,922.31	 	20,243.62	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	6/30/2011	 	1,998,527.64	 	191,679.09	 	18,406.84	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	9/30/2011	 	1,806,890.55	 	193,452.13	 	16,713.81	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	12/31/2011	 	1,613,446.42	 	195,241.56	 	14,924.38	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	3/31/2012	 	1,418,204.06	 	197,047.54	 	13,118.39	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	6/30/2012	 	1,221,157.32	 	190,070.23	 	11,295.71	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	9/30/2012	 	1,022,207.09	 	200,789.78	 	9,456.16	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	12/31/2012	 	821,577.31	 	202,566.35	 	7,599.59	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	3/31/2013	 	619,910.96	 	204,440.09	 	5,725.85	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	9/30/2013	 	414,570.87	 	206,331.15	 	3,034.70	 	0.00	 	210,165.93	 	EUR	 	0.9250000
	12/31/2013	 	208,239.72	 	208,239.72	 	1,926.22	 	0.00	 	210,165.94	 	EUR	 	0.9250000
	

[notary stamp]	
 	

[signature]	
 	

[signature]	
 	

[signature]	
 	

 	
 	

 	
 	

 	
 	

 
	

[notary stamp]	
 	

[signature]	
 	

[signature]	
 	

 	
 	

 	
 	

 	
 	

 	
 	

 

[illegible]

..........................registered

at the Arezzo Land Registry

Record Office

on 7-15-2003

Gen. Reg. 2639—Special Reg. 27 

..........................registered

at the Arezzo Land Registry

Record Office

on 7-21-2003

Gen. Reg. 1488—Special Reg. 2756 

..........................registered

at the Arezzo Land Registry

Record Office

on 8-26-2003

Gen. Reg. 17682—Special Reg. 3169 

[illegible]

[illegible] fourteen

original

AREZZO [illegible 2003]

Dr. Fabio Milloni, Notary

[notary stamp] [signature] 

QuickLinks

Exhibit 10.4

FUNDING AMORTIZATION SCHEDULE MORTGAGE BACKED LINE OF CREDITQuickLinks
 -- Click here to rapidly navigate through this document

Exhibit 10.1  

*** CONFIDENTIAL TREATMENT REQUESTED

UNDER 17 C.F.R. §§ 200.80(b)4, AND 240.24b-2 

 
 

NOTICE OF GRANT AWARD    

	RESEARCH	 	Issue Date: 09/29/2003
	Department of Health and Human Services

Centers for Disease Control and Prevention	 	 

CENTER FOR INFECTIOUS DISEASES, CDC 

Grant
Number: 1 R01 CI000099-01

Principal Investigator: ECKER, DAVID J PHD

Project Title: Automated Simultaneous Detection of Bioterrorism Agents 

PRESIDENT
IBIS THERAPEUTICS

IBIS THERAPEUTICS

1891 RUTHERFORD

CARLSBAD, CA 92008

CARLSBAD, CA 92008

UNITED STATES 

Budget
Period: 09/15/2003 - 09/14/2004

Project Period: 09/15/2003 - 09/14/2006 

Dear
Business Official: 

        The
Centers for Disease Control and Prevention hereby awards a grant in the amount of $2,629,242 (see "Award Calculation" in Section I) to IBIS THERAPEUTICS, INC. in support of
the above referenced project. This award is pursuant to the authority of 42 USC 241 42 CFR 52 and is subject to terms and conditions referenced below. 

        Acceptance
of this award including the Terms and Conditions is acknowledged by the grantee when funds are drawn down or otherwise obtained from the grant payment system. 

        Award
recipients are responsible for reporting inventions derived or reduced to practice in the performance of work under this grant. Rights to inventions vest with the grantee
organization provided certain requirements are met and there is acknowledgement of CDC support. In addition, recipients must ensure that patent and license activities are consistent with their
responsibility to make unique research resources developed under this award available to the scientific community, in accordance with CDC policy. For additional information, please visit
http://www.iedison.gov. 

        If
you have any questions about this award, please contact the individual(s) referenced in the information below. 

Sincerely
yours, 

Mildred
Garner

Grants Management Officer

Centers for Disease Control and Prevention 

See
additional information below 

SECTION I - AWARD DATA - 1 R01 CI000099-01 

	AWARD CALCULATION (U.S. Dollars):	 	 	 
	

Salaries and Wages	
 	
 	

[***]
	

Fringe Benefits	
 	
 	

[***]
	

Personnel Costs	
 	
 	

[***]
	

Consultant Services	
 	
 	

[***]
	

Equipment	
 	
 	

[***]
	

Supplies	
 	
 	

[***]
	

Travel Costs	
 	
 	

[***]
	

Other Costs	
 	
 	

[***]
	

Federal Direct Costs	
 	
 	

[***]
	

Federal F&A Costs	
 	
 	

[***]
	

APPROVED BUDGET	
 	
$	

2,629,242
	

TOTAL FEDERAL AWARD AMOUNT	
 	
$	

2,629,242

        Recommended
future year total cost support, subject to the availability of funds and satisfactory progress of the project, is as follows. 

	02	 	$	2,313,198
	03	 	$	1,036,103

FISCAL
INFORMATION:

        CFDA        93.856

        Number:

EIN: 1330336973A1

Document Number: RCI000099A 

	IC
 
	 	CAN
	 	FY2003
	 	FY2004
	 	FY2005

	CI	 	92100B9	 	2,629,242	 	2,313,198	 	1,036,103

ADMINISTRATIVE
DATA:

PCC: / OC: 41.4A /Processed: GARNERM 030929 1244 

SECTION II - PAYMENT/HOTLINE INFORMATION - 1 R01 CI000099-01 

        For
payment information see Payment Information section in Additional Terms and Conditions. 

        To
report fraud, waste or abuse see Inspector General section in Additional Terms and Conditions. 

SECTION III - TERMS AND CONDITIONS - 1 R01 CI000099-01 

        This
award is based on the application submitted to, and as approved by, the CDC on the above-titled project and is subject to the terms and conditions incorporated either directly or by
reference in the following: 

        a.     The
grant program legislation and program regulation cited in this Notice of Grant Award. 

        b.     The
restrictions on the expenditure of federal funds in appropriations acts, to the extent those restrictions are pertinent to the award. 

        c.     45
CFR Part 74 or 45 CFR Part 92 as applicable. 

        d.     The
PHS Grants Policy Statement, including addenda in effect as of the beginning date of the budget period. 

        e.     This
award notice, INCLUDING THE TERMS AND CONDITIONS CITED BELOW. 

Treatment
of Program Income:

Additional Costs 

Approval
List C0-84-G03 

1.    INCORPORATION: 

        Program
Announcement Number PA-03-080, Bio-defense and Emerging Infectious Diseases Research Opportunities and applicable amendments and the application dated January 30, 2003 are made a
part of this award by reference. 

2.    INDIRECT COSTS: 

        Indirect
Costs are awarded at a rate of 51%, as requested. 

3.    HUMAN
SUBJECTS RESTRICTION:    No Restrictions-Per Summary Statement, SRG concerns noted. 

        Notice:
Under governing regulations, Federal funds administered by the Department of Health and Human Services shall not be expended for research involving human subjects, and
individuals shall not be enrolled in such research, without prior approval by the Office for Human Research Protections (OHRP) of an assurance to comply with the requirements of 45 CFR 46 to protect
human research subjects. 

4.    REPORTING
REQUIREMENTS:    All reports (original and two copies) should be submitted to the CDC Grants Management Officer ("GMO"), ATTN: Grants Management Specialist, Centers
for Disease Control & Prevention, Procurement and Grants Office, AABB, 2920 Brandywine Road, Atlanta, Georgia 30341. 

        a.     An
interim progress narrative report/non-competing continuation application is required to be submitted to the Grants Management Officer, no later than June 1, 2004. The
report must contain the following: (1) Progress on current budget period objectives and activities to include explanation on unmet objectives; (2) Interim Financial Status Report (SF 269). The FSR
would reflect projected unobligated balance as of September 14, 2004; (3) New budget period proposed program objectives and activities; and (4) Detailed line-item budget and justification for next
budget period, September 15, 2004 through September 14, 2005. 

        b.     Annual
Progress Reports are required to be submitted to the Grants Management Officer ninety (90) days after the end of the budget period. The due date is October 14,
2004. 

        c.     An
Annual Financial Status Report (FSR) (SF 269) (Long Form) for the budget period is required to be submitted to the Grants Management Officer ninety 90 days after the
end of the budget period. The due date is December 14, 2004. (NOTE: The FSR is prepared on a budget year and NOT on a cumulative basis. FSR may be downloaded from the following website:
http://www.whitehouse.gov/omb/grants/index.html 

        e.     Audit
Requirement: You must comply with the audit requirements of OMB Circular A-133, revised June 24, 1997 which rescinded OMB Circular A-128 "Audits of State and Local
Governments." Please send a courtesy copy of completed audits and any management letters on a voluntary basis to the following: 

Centers
for Disease Control and Prevention (CDC)

Attention: Head, Acquisition Assistance Oversight and Evaluation

2920 Brandywine Road, NE

Atlanta, Georgia 30341 

        You
are required to ensure that subrecipients receiving CDC funds also meet the requirements of OMB A-133 (total Federal grant or cooperative agreement funds received exceed $300,000).
Additionally, you must also ensure that appropriate corrective action is taken within six months after receipt of the subrecipient audit report in instances of non- compliance with Federal laws and
regulations. You are to consider whether subrecipient audits necessitate adjustment of your own records. 

        If
a subrecipient is not required to have an OMB A-133 audit, you are still required by OMB A-133 to perform adequate monitoring of subrecipient activities. You should require each
subrecipient to permit independent auditors to have access to the subrecipient's records and financial statements. YOU SHOULD INCLUDE THESE REQUIREMENTS IN SUBRECIPIENT CONTRACTS. 

        All
reports must be submitted within the specified time frame and location. Delinquent reporting may impact future funding. 

5.    EXPANDED
AUTHORITIES:    The recipient of this award is granted "expanded authorities" in the administration of the award. The grantee may elect to extend the project period
for up to 12 months without additional funds. At least 10 days prior to the original project end date, the grantee must notify the awarding agency GMO in writing (e-mail or letter) of the extension.
The notification must be signed by the authorizing business official and must include the new project end date. Extensions beyond the initial notification must be REQUESTED by the grantee organization
and be APPROVED by the awarding GMO. 

6.    CORRESPONDENCE:    All
correspondence regarding this award must be identified with the award number as shown at the top right of this page. 

7.    PRIOR
APPROVAL:    In accordance with the Code of Federal Regulations, Part 74, "ALL" requests which require prior approval must bear the signature of an authorized official
of the business office of the grantee organization as well as the principal investigator or program or project director." Any requests received which reflect only one signature will be returned to the
grantee unprocessed. Additionally, any requests involving funding issues must include a new proposed budget and a narrative justification of the requested changes. 

8.    PUBLICATIONS:    Publications,
journal articles, etc. produced under a CDC grant support project must bear an acknowledgment and disclaimer, as appropriate, such as: This
publication (journal article,
etc.) was supported by Grant/Cooperative Agreement Number _____ from (name of awarding agency). Its contents are solely the responsibility of the authors and do not necessarily represent the official
views of (name of awarding agency). 

9.    EQUIPMENT
AND PRODUCTS:    To the greatest extent practicable, all equipment and products purchased with CDC funds should be American-made. 

10.    ACKNOWLEDGMENT
OF FEDERAL SUPPORT:    When issuing statements, press releases, requests for proposals, bid solicitations and other documents describing projects or programs
funded in whole or in part with Federal money, all awardees receiving Federal funds, including and not limited to State and local governments and recipients of Federal research grants, shall clearly
state (1) the percentage of the total costs of the program or project which will be financed with Federal money, (2) the dollar amount of Federal funds for the project or program, and (3) percentage
and dollar amount of the total costs of the project or program that will be financed by nongovernmental sources. 

11.    INSPECTOR
GENERAL:    For your information, the United States Department of Health and Human Services Inspector General maintains a toll-free telephone number, 800-447-8477
(800-HHS-TIPS), for receiving information concerning fraud, waste or abuse under grants and cooperative agreements. Such reports are kept confidential, and callers may decline to give their names if
they choose to remain anonymous. 

12.    PAYMENT INFORMATION 

Automatic
Drawdown: 

        Payment
under this award will be made available through the Department of Health and Human Services (HHS) Payment Management System (PMS). PMS is administered by the Division of Payment
Management, Program Support Center, HHS. PMS will forward the DHHS Manual for Recipients Financed Under the Payment Management System (PMS), PMS-270 and PMS-272 forms. 

        A.    PMS
correspondence, mailed through the U.S. Postal Service, should be addressed as follows: Division of Payment Management, FMS/PSC/HHS, P.O. Box 6021 Rockville, MD
20852. 

        B.    If
a carrier other than the U.S. Postal Service is used, such as United Parcel Service, Federal Express, or other commercial service, the correspondence should be
addressed as follows: Division of Payment Management, FMS/PSC/HHS, Rockwall Building #1, Suite 700, 11400 Rockville Pike, Rockville, MD 20852. 

        To
expedite your first payment from this award, attach a copy of the Notice of Grant/Cooperative Agreement to your payment request form. 

13.    CDC CONTACT NAMES: 

Business
and Grants Policy Contact

Sharron Orum, Grants Management Specialist

Acquisition and Assistance Branch B, CDC

2920 Brandywine Road, Room 3000

Atlanta, Georgia 30341-4146

Telephone: (770) 488-2716

Internet Address: spo2@cdc.gov 

Programmatic
Contact

Barbara Stewart, Public Health Analyst

National Center for Infectious Diseases (NCID)

1600 Clifton Road, C-19

Atlanta, GA 30333

Telephone: (404) 639-0044

Internet Address: BSG2@cdc.gov 

Sharon
Orum, Grants Specialist 

SPREADSHEET

GRANT NUMBER: 1 R01 CI000099-01 

P.I.:
ECKER, DAVID J

INSTITUTION: IBIS THERAPEUTICS, INC. 

	 
	 	YEAR 01
	 	YEAR 02
	 	YEAR 03

	Salaries and Wages	 	[***]	 	[***]	 	[***]
	Fringe Benefits	 	[***]	 	 	 	 
	Personnel Costs	 	[***]	 	[***]	 	[***]
	Consultant Services	 	[***]	 	[***]	 	[***]
	Equipment	 	[***]	 	[***]	 	 
	Supplies	 	[***]	 	[***]	 	[***]
	Travel Costs	 	[***]	 	[***]	 	[***]
	Other Costs	 	[***]	 	[***]	 	 
	

TOTAL FEDERAL DC	
 	

2,222,511	
 	

1,540,363	
 	

687,512
	

TOTAL FEDERAL F&	
 	

406,731	
 	

772,835	
 	

348,591
	TOTAL COST	 	2,629,242	 	2,313,198	 	1,036,103

QuickLinks

NOTICE OF GRANT AWARD

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00058-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00058-of-00352.parquet"}]]